| Age/sex | 43/F | 48/F | 43/F |
| Time from weight-management program initiation to onset | 5 days | 25 days | 10 days |
| Time from herbal pill and LCD initiation to onset | 3 days | 22 days | 7 days |
| Lesion site | Bilateral flank and lower back | Upper chest, axillae, lateral chest, flank, and lower back | Right lateral upper arm |
| Main morphology | Polymorphic erythematous papules | Extensive round or annular erythematous papules and plaques | Localized erythematous papules or papular plaques |
| Peak itch NRS | 2/10 | 1/10 | 4/10 |
| Carbohydrate intake before onset | ≤12 g/meal | ≤12 g/meal | ≤12 g/meal |
| Carbohydrate intake after onset | Approximately 30 g/meal | Approximately 30 g/meal | Approximately 30 g/meal |
| Urine ketone findings around onset | Negative 5 days before and 30 days after onset; intermittently positive during later follow-up | ±5 at 7 days after onset; negative at 34 and 69 days after onset | +15 at 10 days before onset; ±5 at 12 days after onset; intermittently positive during later follow-up |
| Topical treatment | 紫雲膏 (Jaun-go) | 紫雲膏 (Jaun-go) | 紫雲膏 (Jaun-go) |
| Decoction modification after onset | Changed to 十味敗毒散(Sipmipaedok-san) | Changed to 十味敗毒散(Sipmipaedok-san) 7 days after onset | No change for lesion management |
| Clinical course | Markedly improved by Day 8; normal skin by approximately 1 month | Lesions expanded through Day 7; active lesions mostly resolved by approximately 5 weeks | Active lesions mostly resolved by Day 12 |
| Residual hyperpigmentation | Faint pigmentation at Day 8; no persistent reticulated hyperpigmentation | Reticulated hyperpigmentation, subsequently resolved | Faint localized pigmentation |
| Ephedra dose at onset | 7.5 g/day | 11.7 g/day | 9.6 g/day |
| Maximum Ephedra dose during follow-up | 18.0 g/day | 18.0 g/day | 18.0 g/day |
| Recurrence during follow-up | No | No | No |
| Weight change | -5.8 kg | -6.3 kg | -3.5 kg |